Skip to main content

Prescription medicine

Atropine and difenoxin Brand names: Motofen; first approved as Motofen Half-Strength

Atropine and difenoxin (Motofen) is a prescription medicine with an FDA approval on record since 1978. No generic is listed; pharmacies paid $6.91 per Motofen 1-0.025 mg tablet in the October 7, 2026 NADAC survey.

  • No generic listed
  • DEA Schedule IV

Check it at the source: the atropine and difenoxin FDA label on DailyMed (effective March 23, 2026, Legacy Pharma USA Inc.); the NDA 17744 record on Drugs@FDA; every atropine and difenoxin label on DailyMed.

Highlights of the record

FDA label of March 23, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026

Used for

From the label: indications and usage

MOTOFEN ® is indicated as adjunctive therapy in the management of acute nonspecific diarrhea and acute exacerbations of chronic functional diarrhea.

Forms and strengths

  • 1 mg / 0.025 mg

Tablet.

On the market

Earliest approval on file
July 14, 1978 Motofen Half-Strength, Legacy; Drugs@FDA’s file, where older or withdrawn approvals can be missing
Generic approvals
No generic approved
Labelers listed (NDC)
2 of which 0 under generic applications, 2 under brand applications, repackagers included

Supply and safety

Pharmacy cost (NADAC)
$6.91 per tablet Motofen 1-0.025 mg tablet
Shortage (FDA)
No current entry
Recalls by its makers (FDA)
No recall recorded
FAERS reports
26 through July 30, 2026

What is atropine and difenoxin used for?

From the label: indications and usage

MOTOFEN ® is indicated as adjunctive therapy in the management of acute nonspecific diarrhea and acute exacerbations of chronic functional diarrhea.

Conditions named in the indications of atropine and difenoxin's FDA labels, with every medicine labeled for each:

From other atropine and difenoxin labels

Diarrhea: INDICATIONS AND USAGE MOTOFEN ® is indicated as adjunctive therapy in the management of acute nonspecific diarrhea and acute exacerbations of chronic functional diarrhea.

FDA pharmacologic class: Anticholinergic, Antidiarrheal and Cholinergic Muscarinic Antagonist.

Source: FDA drug label (Motofen), Legacy Pharma USA Inc., effective March 23, 2026 (SPL set 1fa11c67-5492-469c-9475-6bfa0e5e9ff8), via openFDA; the full label on DailyMed

Is there a generic for atropine and difenoxin (Motofen)?

No generic atropine and difenoxin is approved (Drugs@FDA, October 8, 2026).

  • 1978 earliest approval on file

Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)

What do pharmacies pay for atropine and difenoxin (Motofen)?

In CMS's NADAC survey of October 7, 2026, pharmacies paid $6.91 per Motofen 1-0.025 mg tablet, about the same as a year earlier. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.

  • Motofen 1-0.025 mg tablet (brand)
$6.96
$6.57
April 2024October 2026
NADAC per unit, October 7, 2026
Strength and formBrand or genericPharmacy cost30 tablets, or one pen or vial12-month change
Motofen 1-0.025 mg tabletBrand$6.91 per tablet$207.40-0.6%

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What does the atropine and difenoxin label say about other medicines?

The atropine and difenoxin label names 1 other medicine in its interaction, contraindication or warning sections. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.

Medicine namedSectionWhat the label says
Meperidinedrug interactionsDrug Interactions Since the chemical structure of difenoxin hydrochloride is similar to meperidine hydrochloride, the concurrent use of MOTOFEN ® with monoamine oxidase inhibitors may, in theory, precipitate a hypertensive crisis.

Check atropine and difenoxin against other medicines

Source: FDA drug label (Motofen), Legacy Pharma USA Inc., effective March 23, 2026 (SPL set 1fa11c67-5492-469c-9475-6bfa0e5e9ff8), via openFDA; the full label on DailyMed

What do FAERS reports show for atropine and difenoxin?

The FDA Adverse Event Reporting System holds 26 reports that list atropine and difenoxin among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 10 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.

The most reported reactions

  • Vomiting (named in the label)4
  • Diarrhoea3
  • Drug Ineffective (a use or a product term, not a reaction)3
  • Nausea (named in the label)3
  • Pain3
  • Product Dose Omission Issue (a use or a product term, not a reaction)3
  • Bone Disorder2
  • Fall2

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026

What else is labeled for the same conditions as atropine and difenoxin?

9 other medicines are given the same way (oral) and in the same FDA class as atropine and difenoxin or labeled mainly for the same use (diarrhea), the same class first. Diarrhea lists all 16 medicines labeled for it, by any route. The first 8 are below. They are listed as records, not as substitutes: whether one can replace another is a prescriber's decision.

MedicineShared indicationGeneric labelers (oral)Pharmacy costShortage
CrofelemerDiarrheanone listedn/aNo current entry
Bismuth subsalicylateDiarrheanone listed$0.0817 per tablet 262 mg tablet chewableNo current entry
LoperamideDiarrhea98 labelers$0.0549 per capsule 2 mg capsuleNo current entry
CiprofloxacinDiarrhea46 labelers$0.123 per tablet 500 mg tabletNo current entry
Dimethicone and loperamideDiarrhea33 labelers$0.286 per unit Gs anti-diarrheal-antigas cpltNo current entry
NitazoxanideDiarrhea4 labelers$82.20 per tablet 500 mg tabletNo current entry
RifaximinDiarrheanone listedn/aNo current entry
OctreotideDiarrheanone listedn/aNo current entry

Every medicine labeled for the same conditions as atropine and difenoxin

Source: FDA drug labels (indications), NDC Directory, NADAC of October 7, 2026, FDA shortages (October 8, 2026)

What next?

Alternatives to atropine and difenoxin
9 medicines for the same use
Other anticholinergics
the pharmacologic class, with prices and generics
Atropine and difenoxin side effects
the label's list beside FAERS reports
Check an interaction
what two or more labels say about each other